SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950103-17-009050
Filing Date
2017-09-20
Accepted
2017-09-20 13:40:10
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1797711
2 GRAPHIC image_002.jpg GRAPHIC 4896
3 GRAPHIC p004.jpg GRAPHIC 141001
4 GRAPHIC image_009.jpg GRAPHIC 31127
5 GRAPHIC image_008.gif GRAPHIC 10883
6 GRAPHIC image_009.gif GRAPHIC 7034
7 GRAPHIC image_010.gif GRAPHIC 10116
8 GRAPHIC image_006.gif GRAPHIC 12230
9 GRAPHIC image_007.gif GRAPHIC 1694
10 GRAPHIC image_006.jpg GRAPHIC 4850
11 GRAPHIC image_007.jpg GRAPHIC 3954
12 GRAPHIC image_008.jpg GRAPHIC 3954
  Complete submission text file 0000950103-17-009050.txt   2118901
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01626 | Film No.: 171093776
SIC: 2836 Biological Products, (No Diagnostic Substances)